20 October 2023
20 October 2023
The companies signed a definitive merger agreement in March 2023.
The counterfeit 1mg Ozempic pre-filled pens were imported from legitimate Austrian and German suppliers.
The European Commission has issued the firms with fines after they were found to have worked together to fix the sales of an antispasmodic drug.
Adcetris/AVD is already approved as a first-line treatment for patients with CD30+ Stage IV Hodgkin lymphoma.
The PACE initiative is funded by Innovate UK, LifeArc, and Medicines Discovery Catapult and has started a funding call for the first $12.1m.
Mablink is still waiting on permission from the French Ministry of the Economy for the deal to be finalised.
The approval is based on the LIBERTY 1 and LIBERTY 2 studies, as well as the SPIRIT 1 and SPIRIT 2 trials.
Endeavor will make upfront and milestone payments of $430m to Hummingbird.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
With only a few approved drugs currently available to treat DN by means other than regulation of blood pressure, innovator products that can treat by targeting other factors such as treatment of dyslipidemia, hypertension, or angiotensin inhibition, among others, is a key area of R&D in the DN space and is likely to pave the way for novel therapies in the near future. However, the treatment landscape is expected to remain unchanged due to limited availability of products in the late-stage pipeline currently.
Give your business an edge with our leading industry insights.
